Bullfrog AI Holdings, Inc. Common Stock

NASDAQ BFRG
$1.14 -0.03 -2.56%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 8.75 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
15.99M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
12.19M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
9.69M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-43.00 %

Upcoming events Bullfrog AI Holdings, Inc. Common Stock

All events
No upcoming events scheduled

Stock chart Bullfrog AI Holdings, Inc. Common Stock

Stock analysis Bullfrog AI Holdings, Inc. Common Stock

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-2.25 -0.52
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
3.32 0.82
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-1.73 -0.24
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.54 -0.05
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-218.93 -8.94

Price change Bullfrog AI Holdings, Inc. Common Stock per year

1.14$ 3.96$
Min Max

Summary analysis Bullfrog AI Holdings, Inc. Common Stock

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Bullfrog AI Holdings, Inc. Common Stock

Revenue and net income Bullfrog AI Holdings, Inc. Common Stock

All parameters

About company Bullfrog AI Holdings, Inc. Common Stock

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, which is in the first phase, for the treatment of Glioblastoma; BF-223, which is in the preclinical stage, to treat Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Address:
325 Ellington Boulevard, Gaithersburg, MD, United States, 20878
Company name: Bullfrog AI Holdings, Inc. Common Stock
Issuer ticker: BFRG
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2023-02-13
Sector: Healthcare
Site: https://www.bullfrogai.com